| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(4-dodecylhexadecyl)- Basic information |
| Product Name: | 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(4-dodecylhexadecyl)- | | Synonyms: | 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(4-dodecylhexadecyl)- | | CAS: | 2922283-38-1 | | MF: | C93H177N3O3 | | MW: | 1385.42 | | EINECS: | | | Product Categories: | | | Mol File: | 2922283-38-1.mol |  |
| | 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(4-dodecylhexadecyl)- Chemical Properties |
| Boiling point | 1147.6±60.0 °C(Predicted) | | density | 0.894±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 14.08±0.46(Predicted) | | form | Oil | | color | Off-white to light yellow |
| | 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(4-dodecylhexadecyl)- Usage And Synthesis |
| Uses | N1,N3,N5-Tris(4-dodecylhexadecyl)benzene-1,3,5-tricarboxamide is an analogue of TT3 (HY-148049). TT3 is an ionizable lipid-like materials for mRNA delivery[1][2]. | | References | [1] Li B, Luo X, Deng B, et al. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.Nano Lett. 2015;15(12):8099-8107. DOI:10.1021/acs.nanolett.5b03528
[2] Jiang C, Mei M, Li B, et al. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo.Cell Res. 2017;27(3):440-443. DOI:10.1038/cr.2017.16 |
| | 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(4-dodecylhexadecyl)- Preparation Products And Raw materials |
|